市场调查报告书
商品编码
1476413
睡茄萃取物市场预测至 2030 年:按类型、形式、功能、分销管道、应用和地区进行的全球分析Ashwagandha Extract Market Forecasts to 2030 - Global Analysis By Type (KSM-66, Sensoril, Hydro-Alcoholic Ashwagandha, Crude Ashwagandha and Other Types), Form, Function, Distribution Channel, Application and By Geography |
根据 Stratistics MRC 的数据,2023 年睡茄萃取物的全球市场规模为 11 亿美元,预计在预测期内将以 13.4% 的复合年增长率增长,并在 2030 年达到 26 亿美元。
睡茄萃取物从睡茄植物的根中提取,是一种用于阿育吠陀医学的古老草药。 睡茄透过调节皮质醇水平帮助身体管理压力。它还支持免疫功能并提高整体健康水平。它富含抗氧化剂,可以对抗发炎,改善大脑功能、记忆力和情绪。此外,睡茄萃取物可以降低血糖值并减轻焦虑和忧郁症状。
研究表明,食用大量睡茄会导致胃部不适、腹泻、呕吐和肝臟病变。它还会刺激肠道内壁并导致其他消化器官系统问题。
人们越来越认识到睡茄的健康益处
随着越来越多人意识到睡茄的潜在健康的益处,对睡茄萃取物产品的需求也相应增加。消费者正在寻求自然疗法来解决各种健康问题,包括压力、焦虑、失眠和免疫支持。此外,製造商正在开发新的配方和交付方法,以使睡茄萃取物对消费者更容易获得和更具吸引力。这种不断增长的需求正在推动睡茄萃取物市场的成长。
有限的临床研究
如果没有可靠的临床研究来支持其健康主张,睡茄萃取物可能很难在医疗保健专业人员和消费者中获得信誉。对产品品质、纯度和潜在副作用的担忧可能会阻止一些消费者购买睡茄萃取物补充品。因此,缺乏科学检验会导致人们对其功效和安全性产生怀疑和不确定性,这可能会阻碍广泛采用和市场成长。
对天然和草药的需求不断增长
随着消费者寻求传统药物的天然替代品,对睡茄萃取物等草药补充品的需求激增。注重健康的个人以及寻求缓解压力、焦虑、疲劳和睡眠障碍等特定健康问题的人都会被睡茄萃取物所吸引。 睡茄被誉为适应性草药,具有缓解压力、免疫支持和整体健康等健康益处,与个人对整体解决方案的偏好非常一致,推动市场成长,我支持您。
可能的副作用
潜在副作用的存在可能会导致卫生当局和监管机构的监管监督。出于消费者安全的考虑,监管机构可能会对睡茄萃取物产品实施更严格的监管,包括标籤要求、剂量限製或在某些地区可能禁止。这可能会阻碍製造商和分销商的市场进入和成长。
COVID-19 的影响
人们对睡茄的适应原特性和阿育吠陀医学传统用途的认识不断提高,正在推动对补充品和萃取物的需求。关闭和健康问题加速了向线上购买管道的转变,推动了市场的进一步成长。此外,研究显示睡茄具有潜在的抗病毒和免疫调节特性,引起了消费者和研究人员的兴趣,有助于提高市场在面对疫情挑战时的弹性。
水醇南非睡茄细分市场预计将在预测期内成为最大的细分市场
水醇南非睡茄细分市场预计将出现良好的成长,因为它代表了这种草药萃取物的特定配方,可能会吸引特定的消费者和产业。众所周知,与其他萃取方法相比,水醇萃取可产生效力更高的浓缩萃取物。这种功效的增强可能会吸引寻求更有效补充品的消费者,从而进一步推动市场成长。
预计在预测期内,缓解焦虑和压力产业的复合年增长率最高
随着人们越来越认识到压力与各种健康问题之间的联繫,以及越来越多的消费者寻求自然疗法来管理压力和焦虑,预计焦虑和压力减轻行业将在预测期内实现最高的复合年增长率。 睡茄作为适应原的声誉使其成为寻求自然缓解压力的个人的有吸引力的选择。消费者基础的扩大可以导致销售增加和市场成长。
预计亚太地区在预测期内将占据最大的市场占有率。 睡茄是一种传统的阿育吠陀草药,几个世纪以来一直用于治疗各种健康状况。随着天然和有机产品越来越受欢迎,亚太地区的消费者越来越意识到睡茄的潜在健康益处。这些好处包括减轻压力和焦虑、改善睡眠品质、增强免疫力和增加能量水平。预计这一趋势将推动该地区对睡茄萃取物产品的需求。
由于人们对阿育吠陀草药(包括睡茄萃取物)的使用的广泛认识以及该地区大量人口的接受,预计北美在预测期内将表现出最高的复合年增长率。人们开始认识到阿育吠陀是瑜伽的姐妹科学。该地区消费者意识的提高和对阿育吠陀药品的需求不断增长预计将在市场上获得巨大的吸引力。此外,美国食品运动营养和营养补充的需求不断增长可能会在预测期内推动北美睡茄萃取物市场的成长。
According to Stratistics MRC, the Global Ashwagandha Extract Market is accounted for $1.1 billion in 2023 and is expected to reach $2.6 billion by 2030 growing at a CAGR of 13.4% during the forecast period. Ashwagandha extract, derived from the roots of the Withania somnifera plant, is an ancient herb used in Ayurvedic medicine. Renowned for its adaptogenic properties, it helps the body manage stress by regulating cortisol levels. It also supports immune function and enhances overall well-being. Rich in antioxidants, it combats inflammation and may improve brain function, memory, and mood. Moreover, Ashwagandha extract may lower blood sugar levels and reduce symptoms of anxiety and depression.
According to the studies, large doses of ashwagandha could cause upset stomach, diarrhoea, and vomiting, liver problems. It may also irritate the intestinal mucosa, leading to other digestive problems.
Rising awareness of the health benefits of ashwagandha
As more people become aware of the potential health benefits of ashwagandha, there is a corresponding increase in demand for ashwagandha extract products. Consumers are seeking natural remedies for various health concerns, including stress, anxiety, insomnia, and immune support, among others. Further manufacturers are developing new formulations and delivery methods to make ashwagandha extract more accessible and appealing to consumers. This heightened demand is driving growth in the ashwagandha extract market.
Limited clinical research
Without robust clinical research backing its health claims, ashwagandha extract may struggle to gain credibility among healthcare professionals and consumers. Concerns about product quality, purity, and potential side effects may deter some consumers from purchasing ashwagandha extract supplements. Thus the absence of scientific validation can create skepticism and uncertainty about its effectiveness and safety, hindering widespread adoption and market growth.
Growing demand for natural and herbal remedies
As consumers increasingly seek natural alternatives to conventional medicines, the demand for herbal supplements like ashwagandha extract has surged. It attracts not only health-conscious individuals but also those seeking relief from specific health concerns, such as stress, anxiety, fatigue, and sleep disturbances. Ashwagandha's reputation as an adaptogenic herb with potential health benefits for stress relief, immune support, and overall well-being aligns well with the preferences of individuals looking for holistic solutions encourage the growth of the market.
Potential side effects
The presence of potential side effects may attract regulatory scrutiny from health authorities and regulatory agencies. Concerns about consumer safety may prompt regulatory bodies to impose stricter regulations on ashwagandha extract products, including labeling requirements, dosage restrictions, or even potential bans in certain regions. This can hinder market access and growth for manufacturers and distributors.
Covid-19 Impact
Increased awareness of ashwagandha's adaptogenic properties and its traditional use in Ayurvedic medicine have fueled demand for supplements and extracts. Lockdowns and health concerns have accelerated the shift towards online purchasing channels, driving further market growth. Additionally, research suggesting potential antiviral and immune-modulatory effects of ashwagandha has sparked interest among consumers and researchers alike, contributing to the resilience of the market amidst the pandemic's challenges.
The hydro-alcoholic ashwagandha segment is expected to be the largest during the forecast period
The hydro-alcoholic ashwagandha segment is estimated to have a lucrative growth, as it represents a specific formulation of this herbal extract that may appeal to certain consumers or industries. Hydro-alcoholic extraction is known to yield a concentrated extract with higher potency compared to other extraction methods. This increased potency may appeal to consumers seeking more potent supplements for health benefits which further drives the growth of the market.
The reduced anxiety and stress segment is expected to have the highest CAGR during the forecast period
The reduced anxiety and stress segment is anticipated to witness the highest CAGR growth during the forecast period, as awareness about the link between stress and various health issues grows, more consumers are seeking natural remedies to manage stress and anxiety. Ashwagandha, with its reputation as an adaptogen, becomes an attractive option for individuals looking for natural stress-relief solutions. This expansion of the consumer base can lead to increased sales and market growth.
Asia Pacific is projected to hold the largest market share during the forecast period. Ashwagandha is a traditional Ayurvedic herb that has been used for centuries to treat a variety of health conditions. With the growing popularity of natural and organic products, consumers in the Asia Pacific region are becoming increasingly aware of the potential health benefits of ashwagandha. These benefits include reducing stress and anxiety, improving sleep quality, boosting immunity, and increasing energy levels. This trend is expected to drive the demand for ashwagandha extract products in the region.
North America is projected to have the highest CAGR over the forecast period, due to extensive awareness about using ayurvedic herbs medicines including ashwagandha extract and acceptance by the large population in the region. People are beginning to discover ayurveda as a sister science of yoga. Increasing consumer awareness and growing demand for ayurvedic medicines products in the region is expected to gain a major traction in the market. Furthermore, growing demand for sports nutrition and dietary supplement in the U.S. is likely to boost the growth of the North America ashwagandha extract market during the forecast period.
Key players in the market
Some of the key players in the Ashwagandha Extract Market include Apex International, Banyan Botanicals Corporation, Dabur India Limited, Himalaya Herbal Healthcare, Kerry Group plc, KSM66 Ashwagandha, Medikonda Nutrients, Natreon Inc, Nature's Answer Inc., NOW Foods Co., Organic India PVT Ltd., Paradise Herbs & Essentials Inc., Patanjali AyurvedIndia, Planetary Herbals Co., Sami-Sabinsa Group, Solaray Inc., Solgar Inc., Swanson Health Products Inc. and Zoic Pharmaceuticals
In March 2024, Banyan Botanicals and other companies in the natural products sector will collaborate to establish data on the greenhouse gas emissions associated with the agricultural production of herbs.
In January 2024, Kerry completes acquisition of science-backed branded botanical extract company Natreon. The branded ingredients in Natreon's portfolio are protected by a wide range of U.S. and foreign patents and supported by a total of 52 clinical studies which support the efficacy of their health benefits.
In January 2024, Tata Consumer Products Ltd (TCPL) announced that it would acquire 100% of Organic India's equity shares. The acquisition will include TCPL's purchase of Capital Foods, the owner of Organic India and Ching's Secret, and Smith & Jones.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.